ALLOMUNE

kits for use in human to human organ transplants comprising one or more of the following components - myelosuppressive agents; antibodies to deplete organ transplant recipient's T cells and NK cells; cytokines; gene therapy vector, namely, a carrier molecule for expressing a gene; human bone marrow cells; and human organs